COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,788 Articles (22,946 medRxiv, 8,842 bioRxiv)

Most recent first Previous |  Page 1686: Articles 16851-16860  | Next

Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2 mRNA vaccinated individuals
Kustin, T., Harel, N., Finkel, U., Perchik, S., Harari, S., Tahor, M., Caspi, I., Levy, R., Leschinsky, M., Ken Dror, S., Bergerzon, G., Gadban, H., Gadban, F., Eliassian, E., Shimron, O., Saleh, L., Ben-Zvi, H., Amichay, D., Ben-Dor, A., Sagas, D., Strauss, M., Shemer Avni, Y., Huppert, A., Kepten, E., Balicer, R. D., Nezer, D., Ben-Shachar, S., Stern, A.
10.1101/2021.04.06.21254882 — Posted: 2021-04-09 Discussion: Onsite | Offsite
Neutralization of SARS-CoV-2 variants by convalescent and vaccinated serum
Bates, T. A., Leier, H. C., Lyski, Z. L., McBride, S. K., Coulter, F. J., Weinstein, J. B., Goodman, J. R., Lu, Z., Siegel, S. A. R., Sullivan, P., Strnad, M., Brunton, A. E., Lee, D. X., Curlin, M. E., Messer, W. B., Tafesse, F. G.
10.1101/2021.04.04.21254881 — Posted: 2021-04-09
Performance of Repeat BinaxNOW SARS-CoV-2 Antigen Testing in a Community Setting, Wisconsin, November-December 2020
Shah, M. M., Salvatore, P. P., Ford, L., Kamitani, E., Whaley, M. J., Mitchell, K., Currie, D. W., Morgan, C. N., Segaloff, H. E., Lecher, S., Somers, T., Van Dyke, M. E., Bigouette, J. P., Delaney, A., DaSilva, J., O'Hegarty, M., Boyle-Estheimer, L., Abdirizak, F., Karpathy, S. E., Meece, J., Ivanic, L., Goffard, K., Gieryn, D., Sterkel, A., Bateman, A., Kahrs, J., Langolf, K., Zochert, T., Knight, N. W., Hsu, C. H., Kirking, H. L., Tate, J. E.
10.1101/2021.04.05.21254834 — Posted: 2021-04-09
Machine Learning based COVID-19 Diagnosis from Blood Tests with Robustness to Domain Shifts
Roland, T., Boeck, C., Tschoellitsch, T., Maletzky, A., Hochreiter, S., Meier, J., Klambauer, G.
10.1101/2021.04.06.21254997 — Posted: 2021-04-09
Machine Learning Identifies Ponatinib as a Potent Inhibitor of SARS-CoV2-induced Cytokine Storm
Chan, M., Vijay, S., McElrath, M. J., Holland, E. C., Gujral, T. S.
10.1101/2021.04.07.438871 — Posted: 2021-04-09
A Comparison of Persistence of SARS-CoV-2 Variants on Stainless Steel
Pottage, T., Garratt, I., Onianwa, O., Spencer, A., Paton, S. E., Dunning, J., Bennett, A. M.
10.1101/2021.04.08.438833 — Posted: 2021-04-09
Genome-wide CRISPR activation screen identifies novel receptors for SARS-CoV-2 entry
Zhu, S., Liu, Y., Zhou, Z., Zhang, Z., Xiao, X., Liu, Z., Chen, A., Dong, X., Tian, F., Chen, S., Xu, Y., Wang, C., Li, Q., Niu, X., Pan, Q., Du, S., Xiao, J., Wang, J., Wei, W.
10.1101/2021.04.08.438924 — Posted: 2021-04-09
Intranasal HD-Ad Vaccine Protects the Upper and Lower Respiratory Tracts of hACE2 Mice against SARS-CoV-2
Cao, H., Mai, J., Zhou, Z., Li, Z., Duan, R., Watt, J., Chen, Z., Bandara, R. A., Li, M., Ahn, S. K., Boon, B., Christie, N., Gray-Owen, S., Kozak, R., Mubareka, S., Rini, J. M., Hu, J., Liu, J.
10.1101/2021.04.08.439006 — Posted: 2021-04-09
The impact of viral mutations on recognition by SARS-CoV-2 specific T-cells
de Silva, T. I., Liu, G., Lindsey, B. B., Dong, D., Shah, D., Mentzer, A. J., Angyal, A., Brown, R., Parker, M. D., Yin, Z., Yao, X., Turtle, L., Dunachie, S., COVID-19 Genomics UK (COG-UK) Consortium, , Maini, M. K., Ogg, G., Knight, J. C., Peng, Y., Rowland-Jones, S. L., Dong, T.
10.1101/2021.04.08.438904 — Posted: 2021-04-08 Discussion: Onsite
Polymersomes decorated with SARS-CoV-2 spike protein receptor binding domain elicit robust humoral and cellular immunity
Volpatti, L. R., Wallace, R. P., Cao, S., Raczy, M., Wang, R., Gray, L. T., Alpar, A. T., Briquez, P. S., Mitrousis, N., Marchell, T. M., Sasso, M. S., Nguyen, M., Mansurov, A., Budina, E., Solanki, A., Watkins, E. A., Schnorenberg, M. R., Tremain, A. C., Reda, J. W., Nicolaescu, V., Furlong, K., Dvorkin, S., Yu, S. S., Manicassamy, B., LaBelle, J. L., Tirrell, M. V., Randall, G., Kwissa, M., Swartz, M., Hubbell, J.
10.1101/2021.04.08.438884 — Posted: 2021-04-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).